SB883 — Relating to patient access to prescription drugs for off-label use for COVID-19 treatment.

SB883 — Relating to patient access to prescription drugs for off-label use for COVID-19 treatment. · Informed CitizenryThis act, known as the Right to Treat Act, amends the Health and Safety Code by adding Chapter 491 concerning off-label use of prescription drugs for COVID-19 treatment. The chapter defines "COVID-…Open in Informed Citizenry